ATAD2 and ovarian serous adenocarcinoma: Additionally, the Kaplan–Meier plot results revealed that increased expression of ATAD2, CCNE1, CDC20, and SMC4 was associated with poor survival in serous ovarian cancer patients (p < 0.05).